Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.03 +0.02 (+1.98%)
At close: Sep 29, 2026 · 4:00 PM EDT

Phio Pharmaceuticals (PHIO) Non-Current Assets (2011 - 2026)

Updated

Phio Pharmaceuticals (PHIO) recorded Non-Current Assets of $9,000 in Q2 2026, up 28.6% from $7,000 a year earlier but down 10.0% from the prior quarter.

Analysis

Phio Pharmaceuticals (PHIO) Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2025, Phio Pharmaceuticals reported Non-Current Assets of $11,000, up 450.0% from FY2024.

  • Annual Non-Current Assets has a five-year compound annual growth rate of -54.7% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $2,000 in FY2024 (-95.2%), $42,000 in FY2023 (-88.6%), $368,000 in FY2022 (-16.9%) and $443,000 in FY2021 (-23.0%).
  • Quarterly Non-Current Assets has ranged from $1,000 in Q3 2024 to $495,000 in Q1 2022 over the past five years.
  • On a year-over-year basis, Non-Current Assets has increased for three consecutive quarters, with growth averaging 69.8% over the last seven quarters.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 450.0% in Q4 2025, against a decline of 99.5% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $10,000 (Q1 2026), $11,000 (Q4 2025) and $12,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Phio Pharmaceuticals 11.73 Mn 11.73 Mn - 9,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,000.00
Mar 31, 2026 10,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 12,000.00
Jun 30, 2025 7,000.00
Mar 31, 2025 4,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 1,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 42,000.00
Sep 30, 2023 211,000.00
Jun 30, 2023 261,000.00
Mar 31, 2023 303,000.00
Dec 31, 2022 368,000.00
Sep 30, 2022 414,000.00
Jun 30, 2022 456,000.00
Mar 31, 2022 495,000.00
Dec 31, 2021 443,000.00
Sep 30, 2021 493,000.00
API Access

Phio Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=PHIO&period=max&api_key=YOUR_API_KEY